Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.88M Buy
102,122
+46,000
+82% +$3.06M 1.49% 27
2026
Q1
$3.52M Sell
56,122
-20,000
-26% -$1.39M 0.83% 32
2025
Q4
$5.05M Sell
76,122
-699
-0.9% -$45.2K 1.15% 29
2025
Q3
$5.17M Buy
76,821
+26,821
+54% +$2.12M 1.28% 29
2025
Q2
$4.36M Buy
+50,000
New +$3.92M 1.43% 26

Other funds holding DXCM

Sector Gamma AS's DXCM Position: Q2 2026 in Review

Sector Gamma AS increased its DexCom (DXCM) stake by 82% in Q2 2026, buying an estimated $3.06M and bringing the position to 102,122 shares worth $6.88M. The position accounts for 1.49% of the portfolio, ranked #27.

Sector Gamma AS first reported a position in DXCM in Q2 2025 and has held it in 5 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sector Gamma AS held 102,122 shares of DexCom worth $6.88M as of Q2 2026.
  • Sector Gamma AS bought 46,000 DexCom shares in Q2 2026, an estimated $3.06M.
  • DexCom made up 1.49% of Sector Gamma AS's portfolio in Q2 2026, its #27 holding.
  • Sector Gamma AS first reported a position in DexCom in Q2 2025 and has held it in 5 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.